Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, August 29 2014 10:16pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Thursday, Aug 28, 2014
·Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology
GlobeNewswire - Thu 4:43 pm ET
·[video] Legal Victory for Ackman and Valeant Pharma
at Bloomberg - Thu 6:53 am ET
·Allergan Attempts to Elude Ackman Bid Fuel Bearish Bets
at Bloomberg - Thu 12:00 am ET
Wednesday, Aug 27, 2014
·Allergan sets date for special shareholder meeting
AP - Wed Aug 27
·Allergan v Valeant: When Will It End?
at - Wed Aug 27
·Columbia Laboratories to participate in the Rodman & Renshaw 16th Annual Global Investment Conference
PR Newswire - Wed Aug 27
·Acura Pharmaceuticals Receives Grant From National Institutes of Health to Fund Limitx(TM) Novel Abuse Deterrent Technology
Marketwire - Wed Aug 27
Tuesday, Aug 26, 2014
·Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws
Business Wire - Tue Aug 26
·Botox Maker Allergan Sets Date for Special Shareholder Meeting
at The New York Times - Tue Aug 26
·[video] Allergan to announce special meeting later today
at CNBC - Tue Aug 26
·Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Marketwire - Tue Aug 26
·Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of Pain
Business Wire - Tue Aug 26
Monday, Aug 25, 2014
·Allergan, Inc. -- Moody's: Special meeting process is credit negative for Allergan
- Mon Aug 25
·Ackman Gains 30% With Burger King, Herbalife Wagers
Bloomberg - Mon Aug 25
·Allergan v. Valeant: Here Comes the Lawsuit
at - Mon Aug 25
·Pershing Square Delivers Votes For Allergan Special Meeting to Push Valeant Deal
at - Mon Aug 25
·Alkermes Submits New Drug Application to FDA for Aripiprazole Lauroxil for Treatment of Schizophrenia
Business Wire - Mon Aug 25
·PRESS DIGEST- Canada - Aug 25
Reuters - Mon Aug 25
Saturday, Aug 23, 2014
·Allergan reviews meeting requests in takeover bid
AP - Sat Aug 23
Friday, Aug 22, 2014
·Pershing Square Submits Requisite Requests from Allergan Shareholders to Call Special Meeting
Business Wire - Fri Aug 22
More Latest News...
Sponsor Results
#1 Stock to Buy Right Now
Here's a recommendation that several top analysts agree on
Pharmaceutical Institute
High-impact training solutions for pharma and biotech
MFCS-EZ _ Flow control
Best performance at the best price. Field proven technology
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?